baito logo
    navigation?.buttons?.createJob?.text
    Green Elephant Biotech header
    Green Elephant Biotech logo
    #biopharma #zellkultur #nachhaltigkeit

    Green Elephant Biotech

    from Giessen

    Green Elephant Biotech GmbH is an innovative company in the biopharmaceutical industry that develops sustainable cell culture systems. With the patented CellScrew® technology and plant-based 96-well plates, it focuses on efficiency and environmental friendliness to make life-saving therapies more accessible.

    Visit website

    Green Elephant Biotech GmbH: Innovation Leader in the Biopharmaceutical Industry

    Green Elephant Biotech GmbH, founded in December 2021 by Dr. Joel Eichmann and Felix Wollenhaupt, is an innovative company specializing in the development and manufacturing of sustainable and efficient cell culture systems for the biopharmaceutical industry.

    Key Products and Services

    The company is known for its revolutionary product, the CellScrew®, a patented cell cultivation technology integrated in an Archimedean screw shape within a roller bottle. This technology allows for continuous mixing of the medium while serving as an extended growth surface for adherent cell cultures. A single CellScrew® 10K can replace up to twelve standard roller bottles, significantly increasing production efficiency and scalability[1][2][5].

    Additionally, Green Elephant Biotech offers 96-well plates made from plant-based plastic (PLA), which provide a sustainable alternative to conventional plates made from non-renewable plastics[1][4].

    Main Mission and Values

    The mission of Green Elephant Biotech is to support the production of life-saving medications and vaccines through efficient, scalable cell cultivation and the use of CO2-neutral materials. The company aims to increase the accessibility and affordability of advanced therapies by reducing production costs and shortening time to market[1][2][4].

    Sustainability Goals and Initiatives

    Green Elephant Biotech is actively committed to sustainability in the healthcare sector. By using plant-based PLA instead of non-renewable plastics, the company contributes to reducing the CO2 emissions caused by the healthcare sector. The global healthcare sector is responsible for about 4.4% of global CO2 emissions, and Green Elephant Biotech offers an efficient way to reduce this footprint with its innovative solutions[1][2][4].

    The company is also dedicated to improving the environmental footprint of its customers by providing efficient and scalable cell culture systems that can be integrated into existing infrastructures to increase production while reducing labor costs[2][5].

    Corporate Culture and Development

    Green Elephant Biotech is a spin-off from the Technical University of Central Hesse in Gießen, Germany. The team consists of experienced professionals from the fields of bioprocessing, business development, and marketing. The company has already won several awards, including the Hessian Founder Award and the Science4Life Venture Cup[2][4][5].

    With locations in Gießen and Berlin, Green Elephant Biotech works closely with customers, business partners, and the research community to develop innovative solutions for the challenges of the biopharmaceutical and biotechnology industry. The company is committed to healthy growth and establishing its product in the market, supported by experienced and well-connected investors[1][4].

    Sources: